Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gentongping
- Development stage
- Unknown
- Lead developer
- Anhui Pioneer Pharmaceutical
- Administration
- Oral
01
Overview
Gentongping Capsules (also known under the brand name Meiyeling) is an oral traditional Chinese medicine (TCM) developed and manufactured by Anhui Pioneer Pharmaceutical. It is formulated to promote blood circulation, dredge collaterals, and relieve pain. The capsule is indicated for the treatment of neck and lumbar spondylosis caused by wind-cold blockage, with symptoms including shoulder and neck pain, limited movement, and upper-limb numbness.
- Brand names
- Meiyeling
- Other names
- Gentongping Capsules根痛平根痛平胶囊
Beyond the preview
Go deeper on gentongping.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gentongping.